We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EBAY:NASDAQeBay Inc. Analysis

Data as of 2026-03-30 - not real-time

$89.21

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

eBay’s stock is trading at $89.21, just above the computed support of $85.52 and well below the DCF‑derived fair value of $31.25, highlighting a significant valuation gap. The company posted a 15% revenue growth, strong gross margin of 71% and a ROE of 40.8%, while delivering a dividend yield of 1.41% with a modest 27% payout ratio. Recent material news includes a better‑than‑expected Q4 earnings beat, upbeat Q1 guidance, and the strategic acquisition of Depop for $1.2 billion, which should enhance its C2C proposition and AI‑driven initiatives. Technical indicators show a bullish price trend and increasing volume, but the MACD remains bearish and volatility is elevated at roughly 33% over 30 days, suggesting short‑term price swings.
Given the overvaluation implied by the DCF, a forward PE of 13.4 versus a trailing PE of 20.9, and a high debt‑to‑equity ratio exceeding 150%, investors should weigh the growth upside against balance‑sheet risks. The consensus target of around $99 offers ~11% upside, aligning with a medium‑term bullish case if the Depop integration and AI execution materialize as expected.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bullish trend but bearish MACD
  • Elevated short‑term volatility
  • Recent earnings beat and guidance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 15% revenue growth and strong operating margins
  • Depop acquisition expanding C2C and fashion resale segment
  • Forward PE compression to ~13x and attractive dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • High ROE and solid free cash flow generation
  • AI‑driven platform enhancements and market share potential
  • Sustainable dividend supported by cash flow despite leverage

Key Metrics & Analysis

Financial Health

Revenue Growth15.00%
Profit Margin18.30%
P/E Ratio20.9
ROE40.85%
ROA7.80%
Debt/Equity155.62
P/B Ratio8.7
Op. Cash Flow$2.0B
Free Cash Flow$741.1M

Technical Analysis

TrendBullish
RSI48.8
Support$85.52
Resistance$95.18
MA 20$90.74
MA 50$89.43
MA 200$87.52
MACDBearish
VolumeIncreasing
Fear & Greed Index67.71

Valuation

Fair Value$31.25
Target Price$99.13
Upside/Downside11.12%
GradeOvervalued
TypeBlend
Dividend Yield1.41%

Risk Assessment

Beta0.57
Volatility32.97%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.